AMT-562

· Multitude Therapeutics (Australia) Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMT-562, covering 2024-07-26 to 2024-07-26. Get the full timeline:

Most recent: Clinical Trial Update: AMT-562 in Patients With Selected Advanced Solid Tumors [Phase 1]